Follow
carmine zoccali
carmine zoccali
Renal Research Institute, New York; Inst. Biol.& Mol.Genetics (BIOGEM), Ariano Irpino and IPNET
Verified email at biogem.it
Title
Cited by
Cited by
Year
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
Gisen Group
The Lancet 349 (9069), 1857-1863, 1997
15331997
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
C Zoccali, SM Bode-Böger, F Mallamaci, FA Benedetto, G Tripepi, ...
The Lancet 358 (9299), 2113-2117, 2001
13302001
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
P Ruggenenti, A Perna, G Gherardi, G Garini, C Zoccali, M Salvadori, ...
The Lancet 354 (9176), 359-364, 1999
11391999
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease
C Zoccali, F Mallamaci, G Tripepi, FA Benedetto, S Cutrupi, S Parlongo, ...
Journal of the American Society of Nephrology 13 (1), 134-141, 2002
11342002
Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome
F Locatelli, B Canaud, KU Eckardt, P Stenvinkel, C Wanner, C Zoccali
Nephrology Dialysis Transplantation 18 (7), 1272-1280, 2003
10422003
Obesity and kidney disease: hidden consequences of the epidemic
CP Kovesdy, S Furth, C Zoccali, World Kidney Day Steering Committee
Physiology international 104 (1), 1-14, 2017
8212017
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
P Ruggenenti, A Perna, G Loriga, M Ganeva, B Ene-Iordache, M Turturro, ...
The Lancet 365 (9463), 939-946, 2005
7692005
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease
C Zoccali, F Mallamaci, S Parlongo, S Cutrupi, FA Benedetto, G Tripepi, ...
Circulation 105 (11), 1354-1359, 2002
7422002
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
KJ Jager, C Kovesdy, R Langham, M Rosenberg, V Jha, C Zoccali
Nephrology Dialysis Transplantation 34 (11), 1803-1805, 2019
7382019
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial
R Thadhani, E Appelbaum, Y Pritchett, Y Chang, J Wenger, H Tamez, ...
Jama 307 (7), 674-684, 2012
6762012
When do we need competing risks methods for survival analysis in nephrology?
M Noordzij, K Leffondré, KJ van Stralen, C Zoccali, FW Dekker, KJ Jager
Nephrology Dialysis Transplantation 28 (11), 2670-2677, 2013
6672013
CKD prevalence varies across the European general population
K Brück, VS Stel, G Gambaro, S Hallan, H Völzke, J Ärnlöv, M Kastarinen, ...
Journal of the American Society of Nephrology 27 (7), 2135-2147, 2016
6582016
Vitamin D levels and patient outcome in chronic kidney disease
P Ravani, F Malberti, G Tripepi, P Pecchini, S Cutrupi, P Pizzini, ...
Kidney international 75 (1), 88-95, 2009
5842009
Sample size calculations: basic principles and common pitfalls
M Noordzij, G Tripepi, FW Dekker, C Zoccali, MW Tanck, KJ Jager
Nephrology dialysis transplantation 25 (5), 1388-1393, 2010
5622010
Subjective global assessment of nutrition in dialysis patients
G Enia, C Sicuso, G Alati, C Zoccali, D Pustorino, A Biondo
Nephrology Dialysis Transplantation 8 (10), 1094-1098, 1993
5621993
Confounding: what it is and how to deal with it
KJ Jager, C Zoccali, A Macleod, FW Dekker
Kidney international 73 (3), 256-260, 2008
5192008
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
KJ Jager, A Kramer, NC Chesnaye, C Couchoud, JE Sánchez-Álvarez, ...
Kidney international 98 (6), 1540-1548, 2020
5112020
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
A Ortiz, A Covic, D Fliser, D Fouque, D Goldsmith, M Kanbay, F Mallamaci, ...
The lancet 383 (9931), 1831-1843, 2014
5072014
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease
C Zoccali, FA Benedetto, R Maas, F Mallamaci, G Tripepi, LS Malatino, ...
Journal of the American Society of Nephrology 13 (2), 490-496, 2002
4912002
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach
P Ravani, G Tripepi, F Malberti, S Testa, F Mallamaci, C Zoccali
Journal of the American Society of Nephrology 16 (8), 2449-2455, 2005
4832005
The system can't perform the operation now. Try again later.
Articles 1–20